unknown
Stage
3
Investors
About
Finnadvance develops multi-channel 3D microfluidic organ-on-chip devices and platforms used by pharmaceutical companies and research organizations to model human organs for preclinical drug discovery and reduce reliance on animal testing.
Explore Finnadvance's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.